Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson
Isomorphic Labs official announcements · 行业原文收录 · 来源发布：Tue Jan 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:08:46 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Listen: Spotify Apple Podcasts Isomorphic Labs announces a cross-modality, multi-target research collaboration with Johnson & Johnson. This partnership brings together Iso’s AI-first approach to drug discovery with Johnson & Johnson’s expertise in drug discovery and development. Isomorphic Labs’ foundational drug design engine is capable of generating drug candidates against challenging targets ac
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。